Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
Event:
ESC Congress 2025
Topic:
Hypertrophic Cardiomyopathy
Session:
Hypertrophic cardiomyopathy: from gene to treatment
